InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

InMode Ltd. Ordinary Shares

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

InMode Ltd.

InMode develops non-invasive and minimally invasive medical aesthetic technology, self-described as providing superior satisfaction for both patients and practices.

Metric
Company Name	InMode Ltd. Ordinary Shares
Symbol	INMD
MSH ID	COM:INMODEMD
Market	STOCKS
Sector	Healthcare
Industry	Medical - Devices
Country	US
Stage
Employee Count	581
Website	inmodemd.com
LinkedIn
Founders

Metric
Market Cap	1.45B
Enterprise Value
Monthly Web Traffic	26.03K
Web Traffic Growth	-0.15
Valuation
Raised Capital

Metric
Revenue	492.05M
Revenue (LTM)
Revenue (NTM)
Gross Profit	411.34M
EBITDA	196.28M
Operating Income	195.66M
Net Income	197.92M
EPS	2.37
Diluted EPS	2.30
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.84
Operating Profit Margin	0.40
EBITDA Margin	0.40
Net Profit Margin	0.40
Return on Equity	0.28
Return on Assets	0.23
Return on Capital Employed	0.24

COM:INMODEMD

InMode

Last Close

18.48

22/11 21:00

Market Cap

1.49B

Beta: -

Volume Today

794.36K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	10.92
P/B Ratio	2.72
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.61
EV Multiple	11.81

Metric
Days Sales Outstanding	45.42
Days Payables Outstanding	55.27
Days Inventory Outstanding	260.00
Operating Cycle	313.58
Cash Conversion Cycle	236.76
Asset Turnover	0.57

Metric
Operating Cash Flow	176.83M
Free Cash Flow	176.12M
Cash Flow to Debt	29.69
Operating Cash Flow/Sales	0.40
Free Cash Flow Yield	0.09

Metric
Cash & Equivalents	144.41M
Accounts Receivable	-16.08M
Inventory	45.09M
Goodwill
Debt to Capitalization	0.01
Debt to Assets	0.00
Current Ratio	12.51
Quick Ratio	12.66

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.05
R&D to Revenue	0.03
SG&A to Revenue	0.02